MoonLake Immunotherapeutics (MLTX)
NASDAQ: MLTX · Real-Time Price · USD
36.35
-2.72 (-6.96%)
At close: Apr 1, 2025, 4:00 PM
37.75
+1.40 (3.84%)
After-hours: Apr 1, 2025, 4:53 PM EDT
MLTX Market Cap
MLTX has a market cap or net worth of $2.30 billion as of April 1, 2025. Its market cap has decreased by -16.43% in one year.
Market Cap
2.30B
Enterprise Value
1.96B
1-Year Change
-16.43%
Ranking
Category
Stock Price
$36.35
Market Cap Chart
Since February 14, 2022, MLTX's market cap has increased from $3.60M to $2.30B, an increase of 63,832.09%. That is a compound annual growth rate of 689.83%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 31, 2025 | 2.47B | -27.60% |
| Dec 31, 2024 | 3.41B | -5.66% |
| Dec 29, 2023 | 3.62B | 784.47% |
| Dec 30, 2022 | 409.26M | 11,274.54% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 738.61B |
| UnitedHealth Group | 472.03B |
| Johnson & Johnson | 394.52B |
| AbbVie | 363.15B |
| Novo Nordisk | 305.46B |
| AstraZeneca | 229.16B |
| Abbott Laboratories | 226.88B |
| Merck & Co. | 225.40B |